A Study of LY2127399 in Participants With Systemic Lupus Erythematosus

Clinical trial NCT01196091 · COMPLETED

Trial details

NCT number: NCT01196091
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Connective Tissue Disease Autoimmune Disease

Start date: 2010-12-01
Primary completion: 2014-07-01
Enrollment: 1164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.